Browse the corpus
Walk the Even Hospital Database by book and chapter — the raw source passages that ground Ask, DDx, and the rest.
1 passage
REFERENCES Doan T and Massarotti E, “Rheumatoid Arthritis: An Overview of New and Emerging Therapies,” J Clin Pharmacol , 2005, 45(7):751-62. [PubMed 15951465 ] Furst DE, Breedveld FC, Kalden JR, et al, “Updated Consensus Statement on Biological Agents for the Treatment of Rheumatic Diseases, 2007,” Ann Rheum Dis , 2007, 66(Suppl 3):2-22. [PubMed 17934088 ] Genovese MC, Becker JC, Schiff M, et al, “Abatacept for Rheumatoid Arthritis Refractory to Tumor Necrosis Factor Alpha Inhibition,” N Engl J Med , 2005, 353(11):1114-23. [PubMed 16162882 ] Kremer JM, Dougados M, Emery P, et al, “Treatment of Rheumatoid Arthritis With the Selective Costimulation Modulator Abatacept: Twelve-Month Results of a Phase IIb, Double-Blind, Randomized, Placebo-Controlled Trial,” Arthritis Rheum , 2005, 52(8):2263-71. [PubMed 16052582 ] Kremer JM, Genant HK, Moreland LW, et al, “Effects of Abatacept in Patients With Methotrexate-Resistant Active Rheumatoid Arthritis: A Randomized Trial,” Ann Intern Med , 2006, 144(12):865-76. [PubMed 16785475 ] Kremer JM, Westhovens R, Leon M, et al, “Treatment of Rheumatoid Arthritis by Selective Inhibition of T-Cell Activation With Fusion Protein CTLA4Ig,” N Engl J Med , 2003, 349(20):1907-15. [PubMed 14614165 ] Singh JA, Furst DE, Bharat A, et al, “2012 Update of the 2008 American College of Rheumatology Recommendations for the Use of Disease-Modifying Antirheumatic Drugs and Biologic Agents in the Treatment of Rheumatoid Arthritis,” Arthritis Care Res (Hoboken) , 2012, 64(5):625-39. [PubMed 22473917 ] Tay L, Leon F, Vratsanos G, et al, “Vaccination Response to Tetanus Toxoid and 23-Valent Pneumococcal Vaccines Following Administration of a Single Dose of Abatacept: A Randomized, Open-Label, Parallel Group Study in Healthy Subjects,” Arthritis Res Ther , 2007, 9(2): R38. [PubMed 17425783 ] Weinblatt M, Combe B, Covucci A, et al, “Safety of the Selective Costimulation Modulator Abatacept in Rheumatoid Arthritis Patients Receiving Background Biologic and Nonbiologic Disease-Modifying Antirheumatic Drugs: A One-Year Randomized, Placebo-Controlled Study,” Arthritis Rheum , 2006, 54(9):2807-16. [PubMed 16947384 ] Topic 8526 Version 38.0 © 2013 UpToDate, Inc. All rights reserved. | Subscription and License Agreement | Release: 21.6- C21.56 Licensed to: AsanBook Dig. Med. Lib. | Support Tag: [1005-83.177.194.223-A277839E2F-S244013.14]